GINA 2020 (19/03/2020). Recomendaciones medicación asma inhalada COVID19 COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
Liu W et al. (2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Factores de riesgo y preventivos / 25 de Abril del 2020 Read more
Sorbello M et al. (2020). The Italian coronavirus disease 2019 outbreak recommendations from clinical practice Información y materiales prácticos de ayuda para farmacéuticos (uso de equipos de protección, limpieza, recomendaciones para población....) / 25 de Abril del 2020 Read more
Tang N et al. (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Tang N. et al. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Vaduganathan M. et al. (2020). Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Cai G (2020).Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
ATS International Task Force (03/04/2020). COVID‐19 Interim Guidance on Management Pending Empirical. Tratamientos e interacciones farmacológicas / 25 de Abril del 2020 Read more
Amgalan A (2020). Letter to de Editor ExPloring possible mechanisms for COVID-19 induced thrombocytopenia Unanswered Questions COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Yin S. et al. (2020). Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more